• Monday,September 23,2024
gecos.fr
X

Tata 1mg FY22 revenue up 66% to Rs 222 cr; net loss narrows to Rs 146 cr

$ 13.50

4.9 (658) In stock

Share

Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler.
Tata group-owned online pharmacy 1mg's revenue from operations rose 65.7 per cent to Rs 222.10 crore in FY22, while its net loss narrowed to Rs 146.30 crore, according to data sourced by business intelligence platform Tofler.

Tata group's e-pharmacy 1mg pares losses to ₹146 cr in FY22 - The Hindu BusinessLine

Tata 1mg FY22 revenue up 66% to ₹222 crore, net loss narrows. Details here

Tata 1MG's growth prescription

Trent Q2 Results: Trent's profit surges nearly three-fold to Rs 228.06 crore in Q2 FY24, ET Retail

Net Loss, Latest & Breaking News on Net Loss

Net Loss, Latest & Breaking News on Net Loss

Tata 1mg overtakes PharmEasy as leaders in India's e-pharmacy market

OneAssist posts Rs 60 Cr loss with flat growth in FY22

Tata Motors becomes the second company after Reliance Industries to cross the Rs 1 lakh crore revenue mark